Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
Content Written By, Reviewed By, or Featuring Sarah Whelan, PhD
Total: 314
News
Largest-Ever Genetic Study on Epilepsy Uncovers Potential Therapeutic Paths
One of the largest and most diverse studies to date on genetic factors related to epilepsy has revealed potential new treatment targets.
Industry Insight
Innovation Award Winner Announced at ELRIG Drug Discovery 2024
Technology Networks had the pleasure of speaking with the ELRIG Innovation Award Winner Constructive Bio’s CEO, Dr. Ola Wlodek, to discuss its award-winning innovations and learn more about its mission.
Article
The Evolving Treatment Landscape for Alzheimer’s
We spoke to Andrew Doig, professor of biochemistry at the University of Manchester, to find out more about the evolving landscape of Alzheimer's treatments.
News
AI Model May Help Guide Cancer Diagnosis and Treatment
Researchers have developed an AI model that can perform an array of diagnostic tasks for multiple forms of cancer, improving upon existing AI systems.
News
Ketogenic Diet Improves Pancreatic Cancer Therapy in Animal Model
A study investigating the effects of fasting and the ketogenic diet has revealed a new vulnerability of pancreatic tumors to a cancer drug currently in clinical trials.
Article
LGBTQIA+ Representation and Creating Inclusive Environments: A Q&A With Dr. Raquel Cuella Martin
In this interview, we spoke to Dr. Raquel Cuella Martin to learn about her research, her experiences working as an LGBTQIA+ researcher in STEMM and her advice for others beginning a STEMM career.
News
New Technique May Reveal Repurposing Potential for Existing Drugs
A new technique may help reveal unknown benefits of existing drugs, according to a new study. The new approach, called decryptE, could help identify new applications for already approved drugs and take steps toward precision medicine.
News
MDMA-Assisted PTSD Therapy Rejected by FDA
The US Food and Drug Administration (FDA) has rejected the use of MDMA-assisted therapy for post-traumatic stress disorder (PTSD), according to an announcement from the therapy’s drugmaker, Lykos Therapeutics.
News
New Compound Restores Memory in Alzheimer’s Mouse Model
A new molecule developed by University of California Los Angeles (UCLA) researchers can restore lost cognitive functions in mice with symptoms of Alzheimer's disease, according to a new study published in PNAS.
News
Drug Candidate Shows Promise in Reversing MS Nerve Damage in Mouse Model
Researchers have developed a drug that shows promise in animal models of multiple sclerosis (MS). If successful in humans, the drug could help to replace the protective insulation around nerve cells lost because of the disease.
Advertisement
